semaglutide weight loss medication GLP-1 Options The Digital Semaglutide Program For

Starting above 2mg dramatically increases the probability of nausea severe enough to compromise nutrition and cause early dropout

The combination of increased pressure and excess acid creates the perfect conditions for retrograde flow, meaning stomach contents push back up through the lower esophageal sphincter and into the esophagus

Orforglipron, developed by Lilly, is also a type of GLP-1 agonist, but its a smaller molecule that doesnt need to be digested by your stomach

Novo Nordisk's oral version of its obesity injection Wegovy could enter the market by year-end, while Eli Lilly's pill orforglipron could launch next year

NOT SURE WHICH APPLIES TO YOU

Not if they are properly designed